(Q34002248)

30 July 2017

1 reference

title

Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem (English)

1 reference

30 July 2017

1

Bodo Melnik

1 reference

30 July 2017

Thomas Jansen

2

1 reference

PubMed ID

17274777

30 July 2017

Stephan Grabbe

series ordinal

3

1 reference

30 July 2017

1 February 2007

1 reference

30 July 2017

1 reference

30 July 2017

5

1 reference

30 July 2017

2

1 reference

30 July 2017

110-117

1 reference

Testosterone and anabolic steroids and acne fulminans

30 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Effects of androgenic-anabolic steroids in athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Stanozolol as a novel therapeutic agent in dermatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Use of multiple drugs among adolescents who use anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Use of anabolic steroids has been reported by 9% of men attending gymnasiums

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Indications of prevalence, practice and effects of anabolic steroid use in Great Britain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Acne induced by 'Sus' and 'Deca'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Prevalence and risk factors for anabolic-androgenic steroid abuse in Australian high school students

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Anabolic steroid use: indications of habituation among adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Exposure to the mass media, body shape concerns, and use of supplements to improve weight and shape among male and female adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Hormonal correlates of acne and hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Role of hormones in pilosebaceous unit development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Androgen receptor expression in the preputial gland and its sebocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Androgen receptor: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Is increased 5 alpha-reductase activity a primary phenomenon in androgen-dependent skin disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Augmentation of lipogenesis by 15-deoxy-Delta12,14-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-Delta12,14-prostaglandin J2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Acne and sebaceous gland function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Sebaceous glands and the prostaglandin pathway--key stones of an exciting mosaic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Testing for anabolic steroids in hair from two bodybuilders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Psychiatric complications of anabolic steroid abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Anabolic-androgenic steroids as a gateway to opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Current perspectives on anabolic steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

The adolescents training and learning to avoid steroids program: preventing drug use and promoting health behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

Evaluation of prevalence of "doping" among Italian athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2007.06176.X

10.1111/J.1610-0387.2007.06176.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

17274777